[Comparative study of 3 different prophylactic programs in hemophiliac children]

Area of Science:

• Pediatric Hematology
• Hemophilia Management
• Prophylactic Therapy

Background:

• Prophylaxis is a key discussion point in pediatric hemophilia therapy.
• Standardized parameters for evaluating prophylactic treatment efficacy are lacking.
• Hemophilia management requires effective strategies to prevent bleeding and joint damage.

Purpose of the Study:

• To evaluate the efficacy of three different prophylactic programs in children with hemophilia.
• To compare outcomes before and after the implementation of prophylactic regimens.
• To assess the impact of early intervention and therapeutic prophylaxis on joint health and quality of life.

Main Methods:

• Implementation of three distinct prophylactic programs in 52 children aged 12 months to 14 years 7 months.
• Comparative analysis of clinical data from the 12 months preceding and following program initiation.
• Evaluation of treatment acceptance by children and parents.

Main Results:

• Continuous prophylaxis demonstrated significant efficacy when initiated early, prior to arthropathy development.
• Therapeutic prophylaxis was more readily accepted for stabilizing target joints.
• Improved quality of life was observed in patients undergoing prophylactic programs.

Conclusions:

• Early initiation of continuous prophylaxis is crucial for effective hemophilia management in children.
• Therapeutic prophylaxis offers a well-accepted alternative for specific joint issues.
• The benefits of prophylactic programs, including enhanced quality of life, justify their associated costs.